The Octanate® immune tolerance induction experience in haemophilia A patients with inhibitors and a poor prognosis:: prospective post-marketing study in progress

被引：0
|
作者：
Zozulya, N. I. . [1 ]
Plyushch, O. P. [1 ]
Severova, T. V. [1 ]
机构：
[1] Moscow Hemophilia Ctr, Moscow, Russia
来源：
HAEMOPHILIA | 2008年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：150 / 150
页数：1
相关论文
共 50 条
  • [41] When is enough ... enough? Developing consensus of definition of failure of immune tolerance induction in patients with haemophilia and inhibitors
    Barnes, C.
    Brown, S. A.
    Curtin, J.
    Dunkley, S.
    HAEMOPHILIA, 2014, 20 (04) : e275 - e279
  • [42] Safety and efficacy of damoctocog alfa pegol prophylaxis in patients with severe haemophilia A: Results of an interventional, post-marketing study
    Holme, Pal Andre
    Poulsen, Lone Hvitfeldt
    Tueckmantel, Claudia
    Enriquez, Monika Maas
    Roman, Maria Teresa Alvarez
    De Cristofaro, Raimondo
    HAEMOPHILIA, 2024, 30 (02) : 388 - 394
  • [43] Low incidence of factor VIII inhibitors in previously untreated patients with severe haemophilia A treated with octanate®: Final report from a prospective study
    Klukowska, A.
    Komrska, V.
    Vdovin, V.
    Pavlova, A.
    Jansen, M.
    Lowndes, S.
    Belyanskaya, L.
    Walter, O.
    Laguna, P.
    HAEMOPHILIA, 2018, 24 (02) : 221 - 228
  • [44] Experience in the treatment of acquired haemophilia A (AHA) in 26 patients in relation to bleeding control and induction of immune tolerance
    Di Prinzio, G.
    Goldmann, G.
    Horneff, S.
    Klein, C.
    Marquardt, N.
    Nadal, J.
    Zeitler, H.
    Oldenburg, J.
    HAEMOPHILIA, 2019, 25 : 94 - 95
  • [45] Immune tolerance induction in adult severe haemophilia a patients with a single FVIII/VWF product: the UK experience
    Rangarajan, S.
    Yee, T. T.
    Roy, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 1081 - 1081
  • [46] Experience with a third generation recombinant factor VIII concentrate (Advate®) for immune tolerance induction in patients with haemophilia A
    Valentino, L. A.
    Recht, M.
    Dipaola, J.
    Shapiro, A. D.
    Pipe, S. W.
    Ewing, N.
    Urgo, J.
    Bullock, T.
    Simmons, M.
    Deguzman, C.
    HAEMOPHILIA, 2009, 15 (03) : 718 - 726
  • [47] Central venous access device (CVAD) complications in Haemophilia with inhibitors undergoing immune tolerance induction: Lessons from the international immune tolerance study
    Rodriguez, V.
    Mancuso, M. E.
    Warad, D.
    Hay, C. R. M.
    Dimichele, D. M.
    Valentino, L.
    Kenet, G.
    Kulkarni, R.
    HAEMOPHILIA, 2015, 21 (05) : E369 - E374
  • [48] Successful primary and rescue immune tolerance induction in adult severe haemophilia A patients with inhibitors using a single FVIII/VWF product - the European experience
    Rangajaran, S.
    Jimenez-Yuste, V.
    Peiro-Jordan, R.
    Santagostino, E.
    HAEMOPHILIA, 2014, 20 : 34 - 34
  • [49] Itopride in the Treatment of Functional Dyspepsia in Chinese Patients A Prospective, Multicentre, Post-Marketing Observational Study
    Sun, Jing
    Yuan, Yao-Zong
    Holtmann, Gerald
    CLINICAL DRUG INVESTIGATION, 2011, 31 (12) : 865 - 875
  • [50] Immune tolerance induction (ITI) in patients with hemophilia A and inhibitors: the Italian retrospective-prospective registry - the PROFIT study
    Santagostino, E.
    Coppola, A.
    Rocino, A.
    Mancuso, M.
    Tagliaferri, A.
    Scaraggi, F.
    Biasoli, C.
    Messina, M.
    Iorio, A.
    Mancuso, G.
    HAEMOPHILIA, 2008, 14 : 57 - 57
12345